KHK4827
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Systemic Sclerosis
Conditions
Systemic Sclerosis
Trial Timeline
Oct 6, 2017 → Mar 31, 2025
NCT ID
NCT04368403About KHK4827
KHK4827 is a phase 1 stage product being developed by Kyowa Kirin for Systemic Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT04368403. Target conditions include Systemic Sclerosis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04368403 | Phase 1 | Completed |
| NCT01782924 | Phase 3 | Completed |
| NCT01782937 | Phase 3 | Completed |
Competing Products
20 competing products in Systemic Sclerosis